RxDoctor Payments Data

Karen Deshotel

Nurse Practitioner · Lafayette, LANPI 1326019258

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $236,250 of the $263,819 with a category attached, or 89.6%. Novartis accounts for 98.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $153,660 and has fallen 99.8% since, to $236 in 2025. Among nurse practitioner clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$263,819in general payments, 2019–2025

Across 38 payments — averaging $6942.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$261K
  • Genentech USA, Inc.$517
  • GSK$472
  • E.r. Squibb & Sons, L.L.C.$425
  • AstraZeneca$226
  • Merck$198
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$236,25090%
  • Travel & lodging$24,4409%
  • Food & beverage$3,0291%
  • Education$1000%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$263,819 in reported general payments places this provider in the 95th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Other nurse practitioner in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →